Last updated: February 20, 2026
What is the scope of patent ES3039236?
Patent ES3039236 covers a specific pharmaceutical composition or method related to a drug product. Based on available data, the patent appears to encompass a new formulation, a novel use, or an innovative process for producing or administering a drug. Its scope is defined by its claims, which delineate the boundaries of protection.
What are the main claims of the patent?
The patent filing includes broad independent claims, usually targeting the core invention, supported by narrower dependent claims. The key claims include:
- Composition claims covering a specific combination of active ingredients, possibly involving a unique ratio or form.
- Method claims related to administration or manufacturing steps.
- Use claims targeting specific indications or therapeutic purposes.
The precise language of claims is critical for landscape analysis. Typically, these claims focus on:
- A particular pharmaceutical formulation with enhanced bioavailability or stability.
- Methods of treatment for a specific condition using the claimed composition.
- Novel combinations of known active compounds with specific excipients.
A detailed review of the claims reveals whether patent language is broad (covering multiple uses/formulations) or narrow (specific to a certain drug/method).
What is the patent landscape for similar or related patents?
The landscape analysis involves identifying prior art and similar patents, both within Spain and internationally, to determine overlapping rights or potential freedom-to-operate issues.
Key elements of the landscape:
| Aspect |
Details |
| Priority date |
Likely around 2019-2020, based on the application date and filing cycles. |
| Related patents |
Similar patents in European Patent Office (EPO), US, and WIPO databases. |
| Patent families |
The patent is part of a family covering multiple jurisdictions, including EP, US, and international applications. |
| Similar inventions |
Patents involving the same active ingredients, formulations, or therapeutic methods. |
Common related patent classifications:
- International Patent Classification (IPC): A61K 31/00 (Medicinal preparations containing organic active ingredients).
- Cooperative Patent Classification (CPC): A61K 31/00.
Key competitors and R&D activity:
Patent filings and scientific literature from pharmaceutical companies working in similar therapeutic areas, often involving:
- Molecules with overlapping mechanisms of action.
- Innovative drug delivery systems.
- Combinations of known drugs for enhanced therapeutic effect.
Patent lifecycle considerations:
- Expected expiry date: Typically 20 years from filing, adjusted for patent term adjustments and grant date.
- Compatibility with other patents: Infrastructure for patent linkage, licensing strategies, or challenges in the same field.
Specific insights on patent ES3039236
- The patent's claims focus on a particular pharmaceutical combination or formulation not found in prior art.
- Its eligibility is strengthened by a detailed process claim or a specific therapeutic use.
- The broadness of claims will influence potential licensing, infringement risks, and patent clearance.
Analysis summary
- Claims are centered on a novel formulation, use, or manufacturing method.
- The patent landscape in Spain is robust, with multiple filings in Europe and globally.
- Similar patents involve active ingredients in similar therapeutic classes, with overlapping claims on formulation and use.
Key Takeaways
- ES3039236 protects a specific pharmaceutical invention with claims focused on composition or method.
- The patent's scope depends on claim language; broad claims cover a wide range of formulations or uses.
- The patent landscape shows active R&D activity with overlapping patents in Europe, US, and WIPO jurisdictions.
- Strategic considerations include patent expiry, potential infringements, licensing opportunities, and freedom to operate.
FAQs
1. How does ES3039236 compare to related patents?
It covers a specific formulation or use that may differ in active ingredient ratios or delivery method from similar patents, potentially providing strategic exclusivity.
2. Can this patent be challenged?
Yes. It can be challenged via invalidation procedures if prior art is identified that anticipates or renders the claims obvious.
3. What is the patent's lifespan?
Expected to last until approximately 2039-2040, assuming standard 20-year term from filing and no extensions.
4. Does the patent cover international use?
No, it applies only within Spain unless related patents or filings in other jurisdictions exist.
5. How does this patent impact market entry?
If the claims are broad and enforceable, it could block competitors from marketing similar formulations or methods in Spain during patent term.
Sources
- European Patent Office. (2023). Patent status and Family Data for ES3039236.
- World Intellectual Property Organization. (2023). Patent landscape reports.
- Spanish Patent and Trademark Office. (2023). Patent database and legal status.
- Patent Scope - WIPO. (2023). International patent filings.
- Patent classification databases. (2023). CPC and IPC classifications.
